Login to Your Account

China rejects 30 more drug applications and tightens regulations

By Pearl Liu
Staff Writer

Tuesday, October 25, 2016

HONG KONG – In an effort to encourage innovation and upgrade China's pharmaceutical sector, China's drug watchdog continues to target companies with weak clinical trial data.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription